Skorpios Trust 13D and 13G filings for Akero Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-09-12 4:30 pm Sale |
2023-09-08 | 13G | Akero Therapeutics, Inc. AKRO |
Skorpios Trust | 0 0.000% |
-3,271,829 (Position Closed) |
Filing |
| 2022-12-05 4:40 pm Sale |
2022-12-01 | 13G | Akero Therapeutics, Inc. AKRO |
Skorpios Trust | 3,271,829 7.000% |
-1,636,000 (-33.33%) |
Filing |
| 2021-06-30 4:17 pm Purchase |
2021-06-21 | 13G | Akero Therapeutics, Inc. AKRO |
Skorpios Trust | 4,907,829 14.100% |
4,907,829 (New Position) |
Filing |